The placenta and preeclampsia: villain or victim?

K Melchiorre, V Giorgione, B Thilaganathan - American journal of obstetrics …, 2022 - Elsevier
Preeclampsia is a disease whose characterization has not changed in the 150 years since
the cluster of signs associated with the disorder were first described. Although our …

Atrial septal defect in adulthood: a new paradigm for congenital heart disease

M Brida, M Chessa, D Celermajer, W Li… - European Heart …, 2022 - academic.oup.com
Atrial septal defects (ASDs) represent the most common congenital heart defect diagnosed
in adulthood. Although considered a simple defect, challenges in optimal diagnostic and …

2018 ESC guidelines for the management of cardiovascular diseases during pregnancy: the task force for the management of cardiovascular diseases during …

V Regitz-Zagrosek, JW Roos-Hesselink… - European heart …, 2018 - academic.oup.com
not override in any way whatsoever the individual responsibility of health professionals to
make appropriate and accurate decisions in consideration of each patient's health condition …

Atrial septal defects

T Geva, JD Martins, RM Wald - The Lancet, 2014 - thelancet.com
Atrial septal defects are the third most common type of congenital heart disease. Included in
this group of malformations are several types of atrial communications that allow shunting of …

Heart failure in pregnant women with cardiac disease: data from the ROPAC

TPE Ruys, JW Roos-Hesselink, R Hall… - Heart, 2014 - heart.bmj.com
Objective Heart failure (HF) is one of the most important complications in pregnant women
with heart disease, causing maternal and fetal mortality and morbidity. Methods This is an …

Uteroplacental blood flow, cardiac function, and pregnancy outcome in women with congenital heart disease

PG Pieper, A Balci, JG Aarnoudse, MAM Kampman… - Circulation, 2013 - Am Heart Assoc
Background—Pregnant women with congenital heart disease (CHD) are susceptible to
cardiovascular, obstetric, and offspring complications. In women with CHD, cardiac …

Maternal and fetal outcomes of admission for delivery in women with congenital heart disease

RM Hayward, E Foster, ZH Tseng - JAMA cardiology, 2017 - jamanetwork.com
Background Women with congenital heart disease (CHD) may be at increased risk for
adverse events during pregnancy and delivery. Objective To compare delivery outcomes …

Use of medication for cardiovascular disease during pregnancy

PG Pieper - Nature Reviews Cardiology, 2015 - nature.com
One-third of women with heart disease use medication for the treatment of cardiovascular
disease (CVD) during pregnancy. Increased plasma volume, renal clearance, and liver …

[HTML][HTML] Pathophysiology of Pre-Eclampsia—Two Theories of the Development of the Disease

J Kornacki, O Olejniczak, R Sibiak, P Gutaj… - International Journal of …, 2023 - mdpi.com
Pre-eclampsia (PE) continues to be a leading cause of maternal and fetal mortality and
morbidity. While substantial progress has been made in understanding the …

Management of pregnancy in patients with congenital heart disease

IS Harris - Progress in cardiovascular diseases, 2011 - Elsevier
Congenital heart diseases are the most common birth defects in humans, affecting
approximately 0.8% of all live births. In the past, many of the more severe defects resulted in …